SCHEMBL17015647

SCHEMBL17015647

c1ccc(-c2ccc(-n3ccc4c3ccc3c5ccccc5n(-c5ccc6c(ccc7ccccc76)c5)c34)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 9/20 0.33
BIRC5 O15392 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HTR7 P34969 1/20 0.32
CA9 Q16790 1/20 0.32
KMT2A Q03164 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HIF1A Q16665 1/20 0.31
CYP1B1 Q16678 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MAPK9 P45984 1/20 0.31
MAPK10 P53779 1/20 0.31
EDNRB P24530 1/20 0.31
EDNRA P25101 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17015649 0.94 PDPK1 (0.35) PDPK1BIRC5KDM4EATML3MBTL1
SCHEMBL17015179 0.94 KDM4E (0.38) PDPK1BIRC5KDM4EATML3MBTL1
SCHEMBL17015651 0.93 PDPK1 (0.33) PDPK1KDM4EATML3MBTL1HTR7
SCHEMBL17015729 0.93 KDM4E (0.31) PDPK1KDM4EATML3MBTL1KMT2A
SCHEMBL17015659 0.93 MAPK9 (0.33) BIRC5KDM4EATML3MBTL1HTR7
SCHEMBL17016132 0.92 KDM4E (0.38) PDPK1BIRC5KDM4EATML3MBTL1
SCHEMBL17015181 0.92 KDM4E (0.38) PDPK1BIRC5KDM4EATML3MBTL1
SCHEMBL17015180 0.91 KDM4E (0.34) PDPK1KDM4EATML3MBTL1CA9
SCHEMBL17016131 0.89 KDM4E (0.41) PDPK1BIRC5KDM4EATML3MBTL1
SCHEMBL17015730 0.89 PDPK1 (0.33) PDPK1KDM4EATML3MBTL1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 US disclosed
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME INMT, IDO1, IDO2 PDPK1 3097/4885BIRC5 654/4885KDM4E 1286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.